Literature DB >> 25159330

Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia.

Torsten P Vahl1, Benedikt A Aulinger1, Eric P Smith1, Deborah L Drazen2, Yve Ulrich-Lai2, Randy J Seeley1, Stephen C Woods2, David A D'Alessio3.   

Abstract

Meal-fed (MF) rats with access to food for only 4 consecutive hours during the light cycle learn to eat large meals to maintain energy balance. MF animals develop behavioral and endocrine changes that permit glucose tolerance despite increased meal size. We hypothesized that enhanced activity of the enteroinsular axis mediates glucose homeostasis during MF. Cohorts of rats were allocated to MF or ad libitum (AL) regimens for 2-4 wk. Insulin secretion and glucose tolerance were determined after oral carbohydrate and intraperitoneal (ip) and intravenous (iv) glucose. MF rats ate less than AL in the first week but maintained a comparable weight trajectory thereafter. MF rats had decreased glucose excursions after a liquid mixed meal (AUC: MF 75 ± 7, AL 461 ± 28 mmol·l⁻¹·min, P < 0.001), with left-shifted insulin secretion (AUC(0-15): MF 31.0 ± 4.9, AL 9.6 ± 4.4 pM·min, P < 0.02), which peaked before a significant rise in blood glucose. Both groups had comparable fasting glucagon levels, but postprandial responses were lower with MF. However, neither intestinal expression of proGIP and proglucagon mRNA nor plasma incretin levels differed between MF and AL groups. There were no differences in the insulin response to ip or iv glucose between MF and AL rats. These findings demonstrate that MF improves oral glucose tolerance and is associated with significant changes in postprandial islet hormone secretion. Because MF enhanced β-cell function during oral but not parenteral carbohydrate administration, and was not accounted for by changes in circulating incretins, these results support a neural mechanism of adaptive insulin secretion.

Entities:  

Keywords:  cephalic insulin secretion; glucose tolerance; insulin sensitivity; meal feeding; time-restricted feeding

Mesh:

Substances:

Year:  2014        PMID: 25159330      PMCID: PMC4216944          DOI: 10.1152/ajpendo.00339.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  38 in total

1.  Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats.

Authors:  S Nausheen; I H Shah; A Pezeshki; D L Sigalet; P K Chelikani
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

2.  Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

Authors:  Carla J Greenbaum; Ronald L Prigeon; David A D'Alessio
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  Diurnal variations in tissue glycogen and liver weight of meal-fed rats.

Authors:  G A Leveille; K Chakrabarty
Journal:  J Nutr       Date:  1967-12       Impact factor: 4.798

4.  Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.

Authors:  Megumi Hatori; Christopher Vollmers; Amir Zarrinpar; Luciano DiTacchio; Eric A Bushong; Shubhroz Gill; Mathias Leblanc; Amandine Chaix; Matthew Joens; James A J Fitzpatrick; Mark H Ellisman; Satchidananda Panda
Journal:  Cell Metab       Date:  2012-05-17       Impact factor: 27.287

5.  Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.

Authors:  Benjamin J Lamont; Yazhou Li; Edwin Kwan; Theodore J Brown; Herbert Gaisano; Daniel J Drucker
Journal:  J Clin Invest       Date:  2011-12-19       Impact factor: 14.808

6.  Influence of dietary fat level on the enzymatic and lipogenic adaptations in adipose tissue of meal-fed rats.

Authors:  G A Leveille
Journal:  J Nutr       Date:  1967-02       Impact factor: 4.798

7.  Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus.

Authors:  C J de Souza; K Gagen; W Chen; N Dragonas
Journal:  Diabetes Obes Metab       Date:  2001-04       Impact factor: 6.577

Review 8.  The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.

Authors:  R E Pratley; C Weyer
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

Review 9.  The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.

Authors:  S Del Prato; A Tiengo
Journal:  Diabetes Metab Res Rev       Date:  2001 May-Jun       Impact factor: 4.876

10.  Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats.

Authors:  Kazunori Fujino; Akio Inui; Akihiro Asakawa; Naoki Kihara; Masaki Fujimura; Mineko Fujimiya
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

View more
  5 in total

1.  Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.

Authors:  Lene Jessen; Eric P Smith; Yvonne Ulrich-Lai; James P Herman; Randy J Seeley; Darleen Sandoval; David D'Alessio
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

2.  Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats.

Authors:  Benedikt A Aulinger; Marta Perabo; Randy J Seeley; Klaus G Parhofer; David A D'Alessio
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-19       Impact factor: 4.310

3.  Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss.

Authors:  J Schmitz; N Evers; M Awazawa; H T Nicholls; H S Brönneke; A Dietrich; J Mauer; M Blüher; J C Brüning
Journal:  Mol Metab       Date:  2016-01-11       Impact factor: 7.422

4.  Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity.

Authors:  Xuemei Shi; Shaji Chacko; Feng Li; Depei Li; Douglas Burrin; Lawrence Chan; Xinfu Guan
Journal:  Mol Metab       Date:  2017-09-01       Impact factor: 7.422

5.  A therapeutic convection-enhanced macroencapsulation device for enhancing β cell viability and insulin secretion.

Authors:  Kisuk Yang; Eoin D O'Cearbhaill; Sophie S Liu; Angela Zhou; Girish D Chitnis; Allison E Hamilos; Jun Xu; Mohan K S Verma; Jaime A Giraldo; Yoshimasa Kudo; Eunjee A Lee; Yuhan Lee; Ramona Pop; Robert Langer; Douglas A Melton; Dale L Greiner; Jeffrey M Karp
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.